Shawn Cross's Net Worth

$398 Thousand

Estimate Recalculated Nov 7, 2024 04:47PM EST

Who is Shawn Cross

Shawn Cross does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Applied Molecular Transport Inc., BioPlus Acquisition Corp., GT Biopharma, Inc., and Cyclo Therapeutics, Inc..

SEC CIK

Shawn Cross's CIK is 0001734779

Past Insider Trading and Trends

2021 was Shawn Cross's most active year for acquiring shares with 4 total transactions. Shawn Cross's most active month to acquire stocks was the month of July. 2023 was Shawn Cross's most active year for disposing of shares, totalling 14 transactions. Shawn Cross's most active month to dispose stocks was the month of November. 2021 saw Shawn Cross paying a total of $46,100.00 for 104,500 shares, this is the most they've acquired in one year. In 2021 Shawn Cross cashed out on 20,000 shares for a total of $301,193.19, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Applied Molecular Transport Inc.

CEO & Chair the Board
Updated Dec 28, 2023
Form 4
-100.00%
-1.75M
Dec 28, 2023
Disposition
Dec 27
Form 4
-16.88%
-110.80K
$0.16
-$18.12K
Nov 24, 2023
545.50K
Sale
Nov 22
Form 4
-12.11%
-90.45K
$0.16
-$14.53K
Nov 16, 2023
656.30K
Sale
Nov 15
Form 4
-0.74%
-5.56K
$0.23
-$1.30K
Oct 04, 2023
746.75K
Sale
Jun 02 - Sep 05
Form 4
1,150.59%
692.15K
$0.16
-$30.74K
Oct 02, 2023
752.31K
Grant
Sep 28 - Sep 29
Form 4
668.00K
Mar 27, 2023
668.00K
Grant
Mar 24
Form 4
-1.53%
-934.00
$0.50
-$467.00
Mar 03, 2023
60.16K
Sale
Mar 01
Form 4
-5.99%
-3.89K
$1.05
-$4.09K
Dec 06, 2022
61.09K
Sale
Dec 02
Form 4
-1.34%
-884.00
$1.42
-$1.26K
Sep 06, 2022
64.98K
Sale
Sep 01
Form 4
-2.85%
-3.93K
$3.01
-$11.83K
Jun 03, 2022
133.85K
Sale
Jun 01 - Jun 02
Form 4
197.10%
102.00K
May 18, 2022
153.75K
Grant
May 16
Form 4
364.29%
114.75K
Feb 16, 2022
146.25K
Grant
Feb 15
Form 4
31.50K
Jan 06, 2022
31.50K
Grant
Dec 24
Form 4
-3.23%
-10.00K
$17.37
-$255.09K
Aug 23, 2021
300.00K
Sale
ScheduledAug 19 - Aug 23
Form 4
63.00K
Mar 03, 2021
63.00K
Grant
Mar 01
Form 3
Jun 04, 2020
Showing 16 results

BioPlus Acquisition Corp.

Investor
Updated Dec 02, 2021
Form 3
Dec 02, 2021
Showing 1 results

GT Biopharma, Inc.

Chief Executive Officer
Updated Mar 16, 2018
Form 3
Mar 16, 2018
Showing 1 results

Cyclo Therapeutics, Inc.

Investor
Updated Aug 20, 2024
Form 4
11.08%
9.03K
Aug 20, 2024
90.52K
Grant
Aug 16
Form 4
33.67%
24.45K
Jun 05, 2024
97.06K
Grant
Jun 03
Form 4
16,151.60%
161.52K
Dec 28, 2023
162.52K
Grant
Dec 27
Form 3
Dec 28, 2023
Showing 4 results

Pacira BioSciences, Inc.

Chief Financial Officer
Updated Nov 05, 2024
Form 4
275.00K
Nov 05, 2024
275.00K
Grant
Nov 01 - Nov 04
Form 3
Oct 23, 2024
Showing 2 results